Jessica Mayer - Cardinal Health Chief Legal and Compliance Officer
CAH Stock | USD 112.54 0.94 0.84% |
Insider
Jessica Mayer is Chief Legal and Compliance Officer of Cardinal Health since 2019.
Age | 54 |
Tenure | 5 years |
Address | 7000 Cardinal Place, Dublin, OH, United States, 43017 |
Phone | 614 757 5000 |
Web | https://www.cardinalhealth.com |
Cardinal Health Management Efficiency
The company has Return on Asset of 0.0279 % which means that on every $100 spent on assets, it made $0.0279 of profit. This is way below average. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities. The Cardinal Health's current Return On Capital Employed is estimated to increase to 0.17, while Return On Assets are projected to decrease to 0.04. As of now, Cardinal Health's Total Current Assets are increasing as compared to previous years. The Cardinal Health's current Intangible Assets is estimated to increase to about 2.2 B, while Non Current Assets Total are projected to decrease to under 6.4 B.Similar Executives
Showing other executives | INSIDER Age | ||
Rachel Vaknin | Microbot Medical | 45 | |
Jon Maack | Definitive Healthcare Corp | N/A | |
Kate Jensen | Definitive Healthcare Corp | 38 | |
Yaron Silberman | Medigus Ltd ADR | 54 | |
Joseph Mirisola | Definitive Healthcare Corp | 40 | |
Daveen Chopra | Edwards Lifesciences Corp | 42 | |
Pr DSc | Microbot Medical | 72 | |
David Kronfeld | Definitive Healthcare Corp | N/A | |
Wei Chen | EUDA Health Holdings | 39 | |
Heisz Stone | Edwards Lifesciences Corp | 58 | |
Todd Brinton | Edwards Lifesciences Corp | N/A | |
Richard Booth | Definitive Healthcare Corp | 55 | |
Steven Sobak | EUDA Health Holdings | 78 | |
Daniel Tan | EUDA Health Holdings | 43 | |
Justin Steinman | Definitive Healthcare Corp | N/A | |
Tali Dinar | Medigus Ltd ADR | 53 | |
Robert JD | Definitive Healthcare Corp | 54 | |
Eyal MD | Microbot Medical | 59 | |
Scott Oberlink | Definitive Healthcare Corp | N/A | |
Tom Penque | Definitive Healthcare Corp | N/A |
Management Performance
Return On Asset | 0.0279 |
Cardinal Health Leadership Team
Elected by the shareholders, the Cardinal Health's board of directors comprises two types of representatives: Cardinal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardinal. The board's role is to monitor Cardinal Health's management team and ensure that shareholders' interests are well served. Cardinal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardinal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Meghan FitzGerald, Executive Vice President - Health Policy and Strategy | ||
Patricia English, Senior President | ||
John Losh, Independent Director | ||
Kevin Moran, VP Relations | ||
David Anderson, Independent Director | ||
Pamela Kimmet, Chief Human Resource Officer | ||
Lisa Capodici, Vice President Investor Relations | ||
Michael Kaufmann, Chief Executive Officer, Director | ||
John Weiland, Independent Director | ||
Sheri Edison, Independent Director | ||
Nancy Killefer, Independent Director | ||
Patricia Hall, Independent Director | ||
Stephen Mason, Chief Executive Officer - Medical Segment | ||
Jon Giacomin, CEO of the Pharmaceutical Segment | ||
Calvin Darden, Independent Director | ||
Akhil Johri, Independent Director | ||
Jorge Gomez, CFO | ||
Michele Holcomb, Executive Vice President - Strategy and Corporate Development | ||
Colleen Arnold, Independent Director | ||
Carrie Cox, Independent Director | ||
Dean Scarborough, Independent Director | ||
Craig Cowman, Ex Services | ||
Deborah Weitzman, Chief Distribution | ||
Jason Hollar, Chief Financial Officer | ||
Matt Sims, Vice Relations | ||
Gregory Kenny, Independent Non-Executive Chairman of the Board | ||
Donald Casey, CEO of Medical Segment | ||
Victor Crawford, Chief Executive Officer - Pharmaceutical segment | ||
George Barrett, Chairman, CEO and Chairman of Executive Committee | ||
Jessica Mayer, Chief Legal and Compliance Officer | ||
Clayton Jones, Independent Director | ||
Craig Morford, Chief Legal and Compliance Officer | ||
Bruce Downey, Independent Director | ||
Mary Scherer, Senior Officer | ||
Brian Rice, Executive Vice President, Chief Information Officer and Customer Support Services | ||
David Evans, Interim Chief Financial Officer | ||
Carole Watkins, Chief Human Resource Officer | ||
Ola Snow, Chief Human Resource Officer | ||
Patricia Morrison, Executive Vice President - Customer Support Services and Chief Information Officer | ||
David King, Independent Director | ||
Michael Losh, Director | ||
Stephen Falk, Executive Vice President General Counsel, Corporate Secretary | ||
Aaron Alt, Chief Officer | ||
Sally Curley, Senior Vice President - Investor Relations | ||
Michelle Greene, Exec Services |
Cardinal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardinal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | 0.0279 | ||||
Profit Margin | 0 % | ||||
Operating Margin | 0.01 % | ||||
Current Valuation | 27.28 B | ||||
Shares Outstanding | 243.23 M | ||||
Shares Owned By Insiders | 0.58 % | ||||
Shares Owned By Institutions | 89.89 % | ||||
Number Of Shares Shorted | 10.65 M | ||||
Price To Earning | 16.00 X | ||||
Price To Book | 16.07 X |
Cardinal Health Investors Sentiment
The influence of Cardinal Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cardinal. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cardinal Health's public news can be used to forecast risks associated with an investment in Cardinal. The trend in average sentiment can be used to explain how an investor holding Cardinal can time the market purely based on public headlines and social activities around Cardinal Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cardinal Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cardinal Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cardinal Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cardinal Health.
Cardinal Health Implied Volatility | 174.38 |
Cardinal Health's implied volatility exposes the market's sentiment of Cardinal Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cardinal Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cardinal Health stock will not fluctuate a lot when Cardinal Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardinal Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardinal Health's short interest history, or implied volatility extrapolated from Cardinal Health options trading.
Pair Trading with Cardinal Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardinal Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardinal Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardinal Stock
0.64 | RNLX | Renalytix AI Report 4th of April 2024 | PairCorr |
Moving against Cardinal Stock
0.91 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.87 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.68 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.67 | MASS | 908 Devices Financial Report 14th of May 2024 | PairCorr |
0.49 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
The ability to find closely correlated positions to Cardinal Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardinal Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardinal Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardinal Health to buy it.
The correlation of Cardinal Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardinal Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardinal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardinal Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.Note that the Cardinal Health information on this page should be used as a complementary analysis to other Cardinal Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Cardinal Stock analysis
When running Cardinal Health's price analysis, check to measure Cardinal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardinal Health is operating at the current time. Most of Cardinal Health's value examination focuses on studying past and present price action to predict the probability of Cardinal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardinal Health's price. Additionally, you may evaluate how the addition of Cardinal Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
CEOs Directory Screen CEOs from public companies around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Cardinal Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Dividend Share 1.998 | Earnings Share 2.52 | Revenue Per Share 859.435 | Quarterly Revenue Growth 0.116 |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.